Eton Pharmaceuticals (ETON) Free Cash Flow (2018 - 2025)

Eton Pharmaceuticals has disclosed Free Cash Flow across 8 years of filings, most recently posting -$11.6 million for Q4 2025.

• Free Cash Flow for Q4 2025 came in at -$11.6 million, down 1392.92% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.2 million (up 980.7% YoY), and the FY2025 annual result was $10.2 million, up 980.7% from the prior year.
• Free Cash Flow came in at -$11.6 million for Q4 2025 at Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $11.7 million in Q3 2025 to a low of -$11.6 million in Q4 2025.
• The 5-year median for Free Cash Flow is $1.0 million (2022), against an average of $900250.0.
• Across the five-year window, Free Cash Flow surged 763.96% in 2022 and sank 1392.92% in 2025, its largest moves.
• Eton Pharmaceuticals' Free Cash Flow stood at -$5.1 million in 2021, then jumped by 155.22% to $2.8 million in 2022, then plunged by 86.32% to $387000.0 in 2023, then sank by 300.78% to -$777000.0 in 2024, then tumbled by 1392.92% to -$11.6 million in 2025.
• The last three Free Cash Flow figures came in at -$11.6 million (Q4 2025), $11.7 million (Q3 2025), and $8.0 million (Q2 2025), per Business Quant data.